Descrição

Cannabigerol and other minor phytocannabinoids are assessed for anti-seizure potential. Preclinical evidence suggests these less-studied compounds may offer complementary mechanisms to cannabidiol.

Figure 18

Chart

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 18: Cannabigerol and other minor phytocannabinoids are assessed for anti-seizure potential. Preclinical evidence suggests these less-studied compounds may offer complementary mechanisms to cannabidiol.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Cannabigerol and other minor phytocannabinoids are assessed for anti-seizure potential. Preclinical evidence suggests these less-studied compounds may offer complementary mechanisms to cannabidiol." />
  <figcaption>Figure 18. Cannabigerol and other minor phytocannabinoids are assessed for anti-seizure potential. Preclinical evidence suggests these less-studied compounds may offer complementary mechanisms to cannabidiol.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Evidências Relacionadas

CBD para Insônia

Nota A · 103 estudos